Feline Tick-Borne Diseases (Ehrlichiosis and Anaplasmosis)

Feline tick-borne diseases caused by Ehrlichia spp. and Anaplasma spp. are zoonotic rickettsial infections transmitted through the bites of infected ticks, belonging to the family Anaplasmataceae [1]. While these organisms have been well characterized in dogs and humans, natural infections in cats are comparatively rare and often underappreciated as a clinical entity in feline medicine [3]. Anaplasma phagocytophilum — the causative agent of granulocytic anaplasmosis — and various Ehrlichia species infect white blood cells, disrupting immune function and causing systemic illness [6]. As tick habitats expand geographically and awareness of feline vector-borne pathogens improves, clinicians are increasingly recognizing these diseases as important differential diagnoses in outdoor or tick-exposed cats [1][4].

Causative Agents

Feline ehrlichiosis and anaplasmosis are caused by obligate intracellular Gram-negative bacteria within the family Anaplasmataceae, order Rickettsiales [1]. In cats, the most clinically relevant organisms include:

• ·Anaplasma phagocytophilum: Infects neutrophils and other granulocytes, causing granulocytic anaplasmosis. This is the best-documented Anaplasma species in cats and is the same organism causing human granulocytic anaplasmosis (HGA) [6].
• ·Ehrlichia canis and related species: Monocytotropic organisms that infect monocytes and macrophages; natural feline infection has been documented, though less commonly than in dogs [2][3].
• ·Anaplasma platys: A platelet-infecting species that may occasionally affect cats [3].

Tick Vectors

A. phagocytophilum is primarily transmitted by Ixodes species ticks, including Ixodes scapularis (black-legged tick) in North America and Ixodes ricinus in Europe [6]. Ehrlichia canis is predominantly vectored by Rhipicephalus sanguineus (the brown dog tick) [2]. Tick transmission typically requires attachment for several hours to days to allow pathogen transfer from tick salivary glands [1].

Pathological Mechanism

Once inoculated into the host, these organisms invade circulating leukocytes — granulocytes in the case of A. phagocytophilum, and monocytes/macrophages in the case of Ehrlichia spp. [1]. They replicate within membrane-bound cytoplasmic vacuoles called morulae (visible on blood smear) and subvert normal immune signaling, including inhibition of apoptosis and interference with oxidative burst mechanisms, allowing persistent intracellular survival [1][2]. The resulting pathology stems from both direct cell injury and an exaggerated host immune-inflammatory response. Key consequences include:

• ·Thrombocytopenia: Caused by immune-mediated platelet destruction, platelet consumption, and bone marrow suppression [1][2]
• ·Anemia: Often immune-mediated or secondary to chronic inflammation [2]
• ·Leukopenia: Particularly during acute infection [6]
• ·Vasculitis and organ dysfunction: Systemic inflammatory responses can damage vascular endothelium, contributing to multiorgan involvement including hepatic, renal, and neurological compromise [1]

Serological and PCR-based studies in North America have confirmed natural feline exposure and infection, though the true prevalence in cats remains incompletely defined [3].

Diagnosis of feline ehrlichiosis and anaplasmosis requires the integration of history, physical examination, laboratory findings, and specific confirmatory testing, since clinical signs are nonspecific [6].

History and Physical Examination

A thorough exposure history is essential — outdoor access, tick infestation, geographic location, and prior travel should all be documented [6]. Physical examination may reveal fever, lymphadenopathy, splenomegaly, pale mucous membranes, or evidence of bleeding [2].

Hematology and Serum Biochemistry

Laboratory abnormalities are common and diagnostically supportive [1][2][6]:

Cytology — Morulae Detection

Examination of blood smears for intracytoplasmic morulae (clusters of organisms within leukocytes) is a rapid, low-cost initial diagnostic step. However, sensitivity is low and absence of morulae does not exclude infection [1][6].

Serology

Indirect fluorescent antibody (IFA) testing and enzyme-linked immunosorbent assay (ELISA) can detect antibodies against A. phagocytophilum or E. canis. Species-specific peptide-based serological assays have been validated for cats and improve diagnostic sensitivity [3]. A fourfold or greater rise in paired titers (acute and convalescent, 2–4 weeks apart) supports active or recent infection [1]. Importantly, seropositivity reflects exposure and does not confirm active infection.

Polymerase Chain Reaction (PCR)

PCR on whole blood is the preferred confirmatory method, offering high sensitivity and species-level identification [1][3][6]. PCR is most reliable when performed during the acute febrile phase before antimicrobial treatment begins. Combined serological and PCR testing is recommended to maximize diagnostic yield in cats [3].

Differential Diagnoses

Other conditions to consider include feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), immune-mediated hemolytic anemia (IMHA), immune-mediated thrombocytopenia (ITP), Cytauxzoon felis infection, Bartonella spp. infection, and other systemic infectious diseases [3][7].

Antimicrobial Therapy

Doxycycline is the treatment of choice for both ehrlichiosis and anaplasmosis in cats, as in dogs and humans [1][2][6]. The recommended protocol is:

• ·Doxycycline: 5–10 mg/kg orally every 12–24 hours for a minimum of 28 days [1][6]
• ·Clinical improvement is typically expected within 24–72 hours of initiating therapy, particularly for A. phagocytophilum infection [6]
• ·Prompt response to doxycycline can serve as a supportive (though non-confirmatory) diagnostic finding

Rifampin has been used as an alternative, particularly for granulocytic anaplasmosis in patients intolerant of tetracyclines, though evidence in cats specifically is limited [1][6]. Fluoroquinolones and beta-lactams are not effective against obligate intracellular rickettsial organisms.

Supportive Care

Supportive treatment is tailored to the severity of clinical signs and laboratory findings:

• ·Fluid therapy: Intravenous crystalloids for dehydrated or hemodynamically compromised patients
• ·Blood transfusions: Indicated in cats with severe anemia (low HCT); packed red blood cells or whole blood may be used [7]
• ·Platelet-rich plasma or fresh whole blood: For cats with clinically significant thrombocytopenia and active bleeding
• ·Nutritional support: Assisted feeding for anorectic patients; hepatoprotective agents (e.g., S-adenosylmethionine) if significant hepatopathy is present
• ·Immunosuppressive therapy: Generally avoided unless concurrent immune-mediated disease is confirmed, as immunosuppression may exacerbate rickettsial infection [2]

Duration and Follow-up

A minimum treatment course of 28 days is recommended to reduce the risk of relapse or chronic carrier states [1]. Re-evaluation of CBC and serum biochemistry at completion of therapy is advisable to confirm hematologic recovery. In dogs, persistent thrombocytopenia after treatment completion raises concern for incomplete clearance; this principle likely applies to cats as well [2].

Overall, feline ehrlichiosis and anaplasmosis carry a favorable prognosis when diagnosed and treated promptly with appropriate antimicrobial therapy [1][6]. Most cats demonstrate rapid clinical improvement (within 24–72 hours) following initiation of doxycycline [6].

However, specific mortality rate data for cats with these diseases are limited in the current veterinary literature, primarily because natural feline infections are relatively rarely reported and documented case series are small [3][6]. The following prognostic considerations are recognized:

• ·Acute, uncomplicated infection: Prognosis is generally good to excellent with timely treatment [1][6]
• ·Chronic or subclinical infection: Cats may remain seropositive for prolonged periods; the clinical significance of persistent infection in cats is not fully established [3]
• ·Severe thrombocytopenia with hemorrhage or significant multi-organ involvement (renal, neurological, hepatic) worsens prognosis [2]
• ·Immunocompromised cats (e.g., FeLV- or FIV-positive) may be at higher risk for severe disease or treatment failure [2]
• ·Delayed diagnosis and treatment, particularly in cats with concurrent illness, may increase morbidity [6]

In dogs, the chronic phase of E. canis infection is associated with severe bone marrow aplasia and a guarded to poor prognosis [2]; an analogous severe chronic syndrome has not been well-characterized in cats, but vigilance is warranted.

Data on long-term prognosis and precise mortality statistics in cats specifically are limited in current veterinary literature; no peer-reviewed feline-specific survival rates were identified in the references cited above.

Tick Control — Primary Strategy

Since tick bite is the obligate route of transmission, effective tick prevention is the cornerstone of disease prevention [1][2][6]:

• ·Acaricidal products: Use of veterinary-approved tick repellents and acaricides for cats (products should be specifically labeled as safe for feline use, as many canine tick products are toxic to cats). Spot-on formulations containing agents such as flumethrin or other feline-safe compounds may reduce tick attachment and feeding [4]
• ·Regular tick checks: Physically inspect cats — especially outdoor cats — for attached ticks after outdoor exposure; prompt removal within the transmission window (several hours) reduces infection risk [6]
• ·Environmental management: Reducing tick habitat around the home (mowing grass, clearing brush, wildlife exclusion) lowers environmental tick burden [1]
• ·Indoor confinement or supervised outdoor access: Limiting free-roaming outdoor access significantly reduces tick exposure risk, particularly in endemic areas [6]

No Available Vaccines

As of current literature, no licensed vaccines exist for feline ehrlichiosis or anaplasmosis [1]. Vaccine development has been explored for canine ehrlichiosis but no feline-specific products are approved [1][2].

Blood Donor Screening

Cats serving as blood donors should be screened for tick-borne pathogens including Ehrlichia and Anaplasma species, particularly those with outdoor access or tick exposure histories, to prevent transfusion-transmitted infection [7].

Zoonotic Awareness

Because A. phagocytophilum and Ehrlichia species are zoonotic pathogens, owners and veterinary personnel should be counseled regarding personal tick protection measures and the shared risk of tick-borne disease in households where pets have tick exposure [1][4]. Direct cat-to-human transmission has not been documented; the shared risk arises from co-exposure to infected ticks rather than from the cats themselves [1].

Monitoring in Endemic Areas

In geographic regions with high tick burden and documented vector-borne disease activity, routine serological or PCR-based screening of at-risk (outdoor) cats may allow early detection of subclinical infections before systemic illness develops [3][4].